Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-02-25 @ 9:50 PM
Study NCT ID:
NCT03157167
Status:
COMPLETED
Last Update Posted:
2025-03-05
First Post:
2017-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
Sponsor:
Navidea Biopharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-04
First Submit QC Date:
None
Study First Post Date:
2017-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-21
Results First Submit QC Date:
None
Results First Post Date:
2025-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-12
Last Update Post Date:
2025-03-05
Last Update Post Date Type:
ACTUAL